VitaNova Life Sciences (VNOV) Other financing activities (2017 - 2023)
VitaNova Life Sciences' (VNOV) quarterly Other financing activities came in at $17282.0 in Q3 2023, up 208.61% on a QoQ basis from $5600.0 in Q1 2019.
VitaNova Life Sciences (VNOV) Other financing activities (2017 - 2023) Analysis & Trends
VitaNova Life Sciences (VNOV) has 4 years of Other financing activities data on file, last reported at $17282.0 in Q3 2023.
- Quarterly Other financing activities changed N/A year-over-year to $17282.0 in Q3 2023, while the trailing twelve-month figure through Apr 2025 was $17282.0 (changed 0.0% YoY) and the FY2024 annual result came in at $957051.0, changed N/A from the prior year.
- Other financing activities climbed to $17282.0 in Q3 2023, from $5600.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $17282.0 in Q3 2023 to a low of $5600.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2023 | 17,282.00 |
| Jul 31, 2023 | 17,282.00 |
| Jan 31, 2019 | 5,600.00 |
| Jan 31, 2019 | 5,600.00 |
| Oct 31, 2018 | -5,600.00 |
| Oct 31, 2018 | -5,600.00 |
| Oct 31, 2017 | -6,000.00 |
| Oct 31, 2017 | -6,000.00 |
| Jul 31, 2017 | 5,700.00 |
| Jul 31, 2017 | 5,700.00 |